|
|
Line 1: |
Line 1: |
| {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | | __NOTOC__ |
| ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Moexipril|{{fontcolor|#6C7B8B|Moexipril}}]]'''''
| | {{Moexipril}} |
| |-
| | |
| ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | UNIVASC<sup>®</sup> FDA Package Insert
| | '''''For patient information about Moexipril, click [[Moexipril (patient information)|here]].''''' |
| |-
| | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril indications and usage|Indications and Usage]]
| | {{SB}} Univasc<sup>®</sup> |
| |-
| | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril dosage and administration|Dosage and Administration]]
| | ==References== |
| |-
| | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril contraindications|Contraindications]]
| | {{Reflist|2}} |
| |-
| | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril warnings and precautions|Warnings and Precautions]]
| | [[Category:Cardiovascular Drugs]] |
| |-
| | [[Category:Drugs]] |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril adverse reactions|Adverse Reactions]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril drug interactions|Drug Interactions]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril use in specific populations|Use in Specific Populations]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril overdosage|Overdosage]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril description|Description]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril clinical pharmacology|Clinical Pharmacology]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril clinical studies|Clinical Studies]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril how supplied storage and handling|How Supplied/Storage and Handling]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril patient counseling information|Patient Counseling Information]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Moexipril labels and packages|Labels and Packages]]
| |
| |-
| |
| ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Moexipril
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
| |
| |-
| |
| |}
| |
Template loop detected: Template:Moexipril
For patient information about Moexipril, click here.
Synonyms / Brand Names: Univasc®
References
For patient information about Moexipril, click here.
Synonyms / Brand Names: Univasc®
References